Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConduit Hldg Regulatory News (CRE)

Share Price Information for Conduit Hldg (CRE)

Share Price is delayed by 15 minutes
Get Live Data
445.00    8.50 (1.95%)
Bid:
444.50
Ask:
445.00
Spread: 0.50 (0.112%)
Market Cap: £658.17m
CRE Live PriceLast checked at - London Stock Exchange

Intraday Conduit Hldg Share Chart

Pre-Close Trading Statement

20 Apr 2010 07:00

RNS Number : 4340K
Creston PLC
20 April 2010
 



20 April 2010

Creston plc

Pre-Close Trading Statement

 

Creston plc ("Creston" or the "Group"; LSE: CRE), the Insight and Communications Group, provides an update on trading in advance of the preliminary results announcement for the year ended 31 March 2010.

 

In its 2010 financial year, the Company performed marginally ahead of the Board's expectations of revenue, Headline EBITDA, Headline EBIT and for net debt.

 

Revenue declined by approximately 4% year-on-year, which was an out performance of the sector. This growth in market share has been driven by good momentum in business from existing and new blue chip clients, plus a contribution from our new start-ups, such as, mobile marketing and digital health.

 

Since the final acquisition earn-out periods all ended in March 2009, our three Divisions of Insight, Communications and Health have continued to work well together, sharing clients, evolving new product offerings and streamlining operational efficiencies within their respective divisions.

 

Total debt has been reduced in the financial year by almost £16 million to £25 million as at 31 March 2010. This is due to an improved working capital position and a strong cash conversion during the second half of the financial year. This reduction in total debt includes the settlement of all final deferred consideration liabilities.

 

Since the final deferred consideration liabilities have now been settled and the cash flow remains robust, it is the Board's intention to recommend a final dividend for shareholder approval.

 

As announced on 26 November 2009, David Grigson took over as Chairman of Creston plc on 1 April 2010 from David Marshall who remains on the Board as a Non-Executive Director.

 

Creston plc expects to announce its preliminary results for the year ended 31 March 2010 on Tuesday, 22 June 2010.

 

-Ends-

 

Enquiries:

 

Creston plc

www.creston.com

Don Elgie, Chief Executive

020 7930 9757

Barrie Brien, COO/CFO

 

 

 

M:Communications

 

Brigitte Trafford

Elly Williamson

 

Investec Bank Plc

Erik Anderson/Carlton Nelson

020 7920 2387

020 7920 2339

 

 

020 7597 5970

 

NOTES TO EDITORS:

 

§ Publication quality photographs are available on www.creston.com.

 

About Creston plc

 

§ Creston is an Insight and Communications company for the 21st century. It offers clients more seamless access to the most innovative marketing insights and communications services to help grow their brands in a rapidly-changing consumer world. Our companies draw upon the collective knowledge, expertise and services from across-the-Group, so that their clients receive the best advice and achieve the best results no matter what the medium. By working together, whether on research or as full-scale marketing partners, our companies continuously innovate to make more things possible for their clients and people.

 

§ Creston companies offer a range of marketing services, such as, market research, direct and digital marketing, public relations, advertising and healthcare marketing to a broad range of blue-chip clients including: AstraZeneca, Aviva, Bayer, BMW, BT, Burger King, Canon, COI Communications, Cow & Gate, Diageo, E-on, First Direct, GlaxoSmithKline, Halifax, Homeform, Kimberly-Clark, Lexus, Lloyds Black Horse, Morrisons, Nissan, Pfizer, Roche, Royal Mail, SAB Miller, Sainsbury's, Tesco, Thorpe Park, Toshiba, Trinity Mirror, T-Mobile, Tropicana, Unilever, Vauxhall, Vodafone, Walkers and WH Smith.

 

§ Creston's share price is quoted in the Financial Times, The Daily Telegraph, The Times and the London Evening Standard.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGGURACUPUGQB
Date   Source Headline
22nd Jul 20244:51 pmRNSNotice of Results
12th Jul 20246:21 pmRNSHolding(s) in Company
24th Jun 20247:00 amRNSDirector/PDMR Shareholding
24th Jun 20247:00 amRNSDirector/PDMR Shareholding
12th Jun 202412:48 pmRNSHolding(s) in Company
30th May 20247:00 amRNSHolding(s) in Company
28th May 20247:00 amRNSDirector/PDMR Shareholding
23rd May 20243:26 pmRNSDirector/PDMR Shareholding
23rd May 20247:00 amRNSHolding(s) in Company
23rd May 20247:00 amRNSPurchase of Shares by Employee Benefit Trust
22nd May 20247:00 amRNSPurchase of Shares by Employee Benefit Trust
21st May 20247:00 amRNSPurchase of Shares by Employee Benefit Trust
17th May 20244:21 pmRNSDirector/PDMR Shareholding
16th May 20247:00 amRNSResult of AGM
15th May 20247:00 amRNSQ1 Trading Update
15th May 20247:00 amRNSDirectorate Change
3rd May 20244:00 pmRNSNotice of Results
30th Apr 20247:00 amRNSHolding(s) in Company
25th Apr 20244:11 pmRNSHolding(s) in Company
19th Apr 20247:00 amRNSHolding(s) in Company
18th Apr 20247:00 amRNSHolding(s) in Company
12th Apr 20247:00 amRNSDirector/PDMR Shareholding
12th Apr 20247:00 amRNSNotice of AGM
8th Apr 20244:34 pmRNSDirector/PDMR Shareholding
4th Apr 20243:52 pmRNSDirector/PDMR Shareholding
28th Mar 20243:53 pmRNSDirector/PDMR Shareholding
27th Mar 20247:00 amRNSDirector/PDMR Shareholding
25th Mar 20244:49 pmRNSDirector/PDMR Shareholding
25th Mar 20244:49 pmRNSDirector/PDMR Shareholding
25th Mar 20244:48 pmRNSDirector/PDMR Shareholding
25th Mar 20244:48 pmRNSDirector/PDMR Shareholding
12th Mar 20243:11 pmRNSHolding(s) in Company
7th Mar 20245:52 pmRNSPurchase of Shares by Employee Benefit Trust
6th Mar 20243:53 pmRNSPurchase of Shares by Employee Benefit Trust
6th Mar 20247:00 amRNSHolding(s) in Company
5th Mar 20244:48 pmRNSPurchase of Shares by Employee Benefit Trust
4th Mar 20243:58 pmRNSPurchase of Shares by Employee Benefit Trust
1st Mar 20244:00 pmRNSPurchase of Shares by Employee Benefit Trust
28th Feb 20241:40 pmRNSAnnual Financial Report
28th Feb 20247:00 amRNSPurchase of Shares by Employee Benefit Trust
28th Feb 20247:00 amRNSHolding(s) in Company
26th Feb 20245:44 pmRNSPurchase of Shares by Employee Benefit Trust
26th Feb 20247:00 amRNSPurchase of Shares by Employee Benefit Trust
21st Feb 20247:00 amRNSAppointment of Senior Independent Director
21st Feb 20247:00 amRNSPreliminary results for the year ended 31/12/2023
13th Feb 20247:00 amRNSNotice of Full Year 2023 Trading Update
29th Jan 20247:00 amRNSPerformance Update
25th Jan 20247:00 amRNSJanuary 2024 Trading Update
15th Jan 20247:00 amRNSNotice of 1 January 2024 Renewals Trading Update
14th Dec 20235:39 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.